Diagnosis and treatment of cervical lymph metastasis carcinoma from unknown primary tumor
He Meilin, Yi Junlin
Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
Abstract：Cervical lymph metastasis carcinoma from unknown primary tumor (CCUP) accounts for 3% to 5% of all malignant tumors of head and neck. With the development of PET-CT, molecular pathology, endoscopy and other auxiliary examinations and the advancement of radiotherapy technology, the diagnostic and treatment levels of CCUP have been gradually improved. Surgery and radiotherapy are the most important treatment methods of CCUP. However, due to its low incidence and heterogeneity, prospective clinical trial data are still lacking. Hence, the optimal therapy of CCUP remains highly controversial. In this article, research progresses on the diagnosis and treatment of CCUP in recent years were reviewed.
He Meilin,Yi Junlin. Diagnosis and treatment of cervical lymph metastasis carcinoma from unknown primary tumor[J]. Chinese Journal of Radiation Oncology, 2022, 31(7): 649-654.
[1] Pavlidis N, Pentheroudakis G.Cancer of unknown primary site[J]. Lancet, 2012, 379(9824):1428-1435. DOI: 10.1016/S0140-6736(11)61178-1. [2] Strojan P, Ferlito A, Langendijk JA, et al.Contemporary management of lymph node metastases from an unknown primary to the neck: ii. a review of therapeutic options[J]. Head Neck, 2013, 35(2):286-293. DOI: 10.1002/hed.21899. [3] Kennel T, Garrel R, Costes V, et al.Head and neck carcinoma of unknown primary[J]. Eur Ann Otorhinolaryngol Head Neck Dis, 2019, 136(3):185-192. DOI: 10.1016/j.anorl.2019.04.002. [4] Arosio AD, Pignataro L, Gaini RM, et al.Neck lymph node metastases from unknown primary[J]. Cancer Treat Rev, 2017, 53:1-9. DOI: 10.1016/j.ctrv.2016.11.014. [5] Strojan P, Ferlito A, Langendijk JA, et al.Contemporary management of lymph node metastases from an unknown primary to the neck: ii. a review of therapeutic options[J]. Head Neck, 2013, 35(2):286-293. DOI: 10.1002/hed.21899. [6] Dou S, Li R, Zhang L, et al.Long-term results of elective mucosal irradiation for head and neck cancer of unknown primary in Chinese population: the EMICUP study[J]. Cancer Med, 2020, 9(5):1712-1720. DOI: 10.1002/cam4.2856. [7] Weir L, Keane T, Cummings B, et al.Radiation treatment of cervical lymph node metastases from an unknown primary: an analysis of outcome by treatment volume and other prognostic factors[J]. Radiother Oncol, 1995, 35(3):206-211. DOI: 10.1016/0167-8140(95)01559-y. [8] Ligey A, Gentil J, Créhange G, et al.Impact of target volumes and radiation technique on loco-regional control and survival for patients with unilateral cervical lymph node metastases from an unknown primary[J]. Radiother Oncol, 2009, 93(3):483-487. DOI: 10.1016/j.radonc.2009.08.027. [9] Dou S, Qian W, Ji Q, et al.Tailored multimodality therapy guided by a two-step decision making process for head-and-neck cancer of unknown primary[J]. Oncotarget, 2016, 7(26):40095-40105. DOI: 10.18632/oncotarget.9492. [10] Beldì D, Jereczek-Fossa BA, D'Onofrio A, et al. Role of radiotherapy in the treatment of cervical lymph node metastases from an unknown primary site: retrospective analysis of 113 patients[J]. Int J Radiat Oncol Biol Phys, 2007, 69(4):1051-1058. DOI: 10.1016/j.ijrobp.2007.04.039. [11] López F, Rodrigo JP, Silver CE, et al. Cervical lymph node metastases from remote primary tumor sites[J]. Head Neck, 2016, 38Suppl 1(Suppl 1):E2374-2385. DOI: 10.1002/hed.24344. [12] Le NS, Janik S, Simmel H, et al.Bilateral vs ipsilateral adjuvant radiotherapy in patients with cancer of unknown primary of the head and neck: an analysis of the clinical outcome and radiation-induced side effects[J]. Head Neck, 2019, 41(6):1785-1794. DOI: 10.1002/hed.25637. [13] Stelow EB, Yaziji H.Immunohistochemistry, carcinomas of unknown primary, and incidence rates[J]. Semin Diagn Pathol, 2018, 35(2):143-152. DOI: 10.1053/j.semdp.2017.11.012. [14] Lin F, Liu H.Immunohistochemistry in undifferentiated neoplasm/tumor of uncertain origin[J]. Arch Pathol Lab Med, 2014, 138(12):1583-1610. DOI: 10.5858/arpa.2014-0061-RA. [15] Hainsworth JD, Greco FA.Gene expression profiling in patients with carcinoma of unknown primary site: from translational research to standard of care[J]. Virchows Arch, 2014, 464(4):393-402. DOI: 10.1007/s00428-014-1545-2. [16] Economopoulou P, Mountzios G, Pavlidis N, et al.Cancer of unknown primary origin in the genomic era: elucidating the dark box of cancer[J]. Cancer Treat Rev, 2015, 41(7):598-604. DOI: 10.1016/j.ctrv.2015.05.010. [17] Taberna M, Mena M, Pavón MA, et al.Human papillomavirus-related oropharyngeal cancer[J]. Ann Oncol, 2017, 28(10):2386-2398. DOI: 10.1093/annonc/mdx304. [18] Martinez RC, Sathasivam HP, Cosway B, et al.Clinicopathological features of squamous cell carcinoma of the oral cavity and oropharynx in young patients[J]. Br J Oral Maxillofac Surg, 2018, 56(4):332-337. DOI: 10.1016/j.bjoms.2018.03.011. [19] Begum S, Gillison ML, Nicol TL, et al.Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck[J]. Clin Cancer Res, 2007, 13(4):1186-1191. DOI: 10.1158/1078-0432.CCR-06-1690. [20] Lam EW, Chan JY, Chan AB, et al.Prevalence, clinicopathological characteristics, and outcome of human papillomavirus-associated oropharyngeal cancer in southern Chinese patients[J]. Cancer Epidemiol Biomarkers Prev, 2016, 25(1):165-173. DOI: 10.1158/1055-9965.EPI-15-0869. [21] Zhang Y, Zhang B, Zhou H, et al.Clinical features and expressions of p16, p53 protein of human papillomavirus- related tonsillar carcinoma[J]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi(Chin J Otorhinolaryngol Head Neck Surg), 2015, 50(2):131-137. [22] Hay A, Ganly I.Targeted therapy in oropharyngeal squamous cell carcinoma: the implications of HPV for therapy[J]. Rare Cancers Ther, 2015, 3(1):89-117. DOI: 10.1007/s40487-015-0008-5. [23] Lewis JS, Beadle B, Bishop JA, et al.Human papillomavirus testing in head and neck carcinomas: guideline from the college of American pathologists[J]. Arch Pathol Lab Med, 2018, 142(5):559-597. DOI: 10.5858/arpa.2017-0286-CP. [24] Stelow EB, Wenig BM.Update from the 4th edition of the world health organization classification of head and neck tumours: nasopharynx[J]. Head Neck Pathol, 2017, 11(1):16-22. DOI: 10.1007/s12105-017-0787-0. [25] Lydiatt WM, Patel SG, O'Sullivan B, et al. Head and neck cancers-major changes in the American joint committee on cancer eighth edition cancer staging manual[J]. CA Cancer J Clin, 2017, 67(2):122-137. DOI: 10.3322/caac.21389. [26] 刘红红, 兰晓莉, Anand Gungadin, 等. 18F-FDGPET／CT对原发灶不明颈部淋巴结转移癌的诊断及预后价值[J]. 中华核医学与分子影像杂志, 2016, (1): 48-53. DOI: 10.3760/cma.j.issn.2095-2848.2016.01.012. Liu HH, Lan XL, Gungadin A, et al.Diagnostic and prognostic values of 18 F-FDG PET/CT in cervical nodal metastatic carcinoma of un-known primary site[J].Chin J Nucl Med Mol Imaging,2016,(1):48-53. DOI: 10.3760/cma.j.issn.2095- 2848.2016.01.012. [27] Zhu L, Wang N.18F-fluorodeoxyglucose positron emission tomography-computed tomography as a diagnostic tool in patients with cervical nodal metastases of unknown primary site: a meta-analysis[J]. Surg Oncol, 2013, 22(3):190-194. DOI: 10.1016/j.suronc.2013.06.002. [28] Ryan JL, Aaron VD, Sims JB.PET/MRI vs PET/CT in head and neck imaging: when, why, and how?[J]. Semin Ultrasound CT MR, 2019, 40(5):376-390. DOI: 10.1053/j.sult.2019.07.002. [29] 倪晓光, 程荣荣, 赖少清, 等. 窄带成像内镜在原发灶不明的颈部转移性鳞癌诊断中的作用[J]. 中华肿瘤杂志, 2013, 35(9): 698-702. DOI: 10.3760/cma.j.issn.0253- 3766.2013.09.012. Ni XG, Cheng RR, Lai SQ, et al.Value of narrow band imaging endoscopy in the detection of unknown primary site with cervical lymph node metastasis of squamous cell carcinoma[J].Chin J Oncol,2013,35(9):698-702. DOI: 10.3760/cma.j.issn.0253-3766.2013.09.012. [30] Filauro M, Paderno A, Perotti P, et al.Role of narrow-band imaging in detection of head and neck unknown primary squamous cell carcinoma[J]. Laryngoscope, 2018, 128(9):2060-2066. DOI: 10.1002/lary.27098. [31] Sokoya M, Chowdhury F, Kadakia S, et al.Combination of panendoscopy and positron emission tomography/computed tomography increases detection of unknown primary head and neck carcinoma[J]. Laryngoscope, 2018, 128(11):2573-2575. DOI: 10.1002/lary.27268. [32] Durmus K, Rangarajan SV, Old MO, et al.Transoral robotic approach to carcinoma of unknown primary[J]. Head Neck, 2014, 36(6):848-852. DOI: 10.1002/hed.23385. [33] Meccariello G, Cammaroto G, Ofo E, et al.The emerging role of trans-oral robotic surgery for the detection of the primary tumour site in patients with head-neck unknown primary cancers: A meta-analysis[J]. Auris Nasus Larynx, 2019, 46(5):663-671. DOI: 10.1016/j.anl.2019.04.007. [34] 张亚民, 戴耀章, 王刘中, 等. 原发灶不明的颈部淋巴结转移癌的治疗探讨[J]. 肿瘤基础与临床, 2018, 31(2): 170-173. DOI: 10.3969/j.issn.1673-5412.2018.02.027. Zhang YM, Dai YZ, Wang LZ, et al.Study on the treatment of cervical lymph metastasis carcinoma of unknown primary tumor[J].J Basic Clin Oncol, 2018, 31(2): 170-173. DOI:10.3969/j.issn.1673-5412.2018.02.027. [35] Galloway TJ, Ridge JA.Management of squamous cancer metastatic to cervical nodes with an unknown primary site[J]. J Clin Oncol, 2015, 33(29):3328-3337. DOI: 10.1200/JCO.2015.61.0063. [36] 窦圣金, 钱薇, 李烿烿, 等. 92例原发灶不明的颈部转移性癌治疗失败模式分析[J]. 中华放射肿瘤学杂志, 2017, 26(1): 12-16. DOI: 10.3760/cma.j.issn.1004-4221.2017.01.003. Dou SJ,Qian W, Li TT, et al.Patterns of failure in head-and-neck cancer of unknown primary:a study of 92 patientshead-and-neck cancer of unknown primary[J].Chin J Radiat Oncol,2017,26(1):12-16. DOI: 10.3760/cma.j.issn.1004-4221.2017.01.003. [37] Richards TM, Bhide SA, Miah AB, et al.Total mucosal irradiation with intensity-modulated radiotherapy in patients with head and neck carcinoma of unknown primary: a pooled analysis of two prospective studies[J]. Clin Oncol (R Coll Radiol), 2016, 28(9):e77-e84. DOI: 10.1016/j.clon.2016.04.035. [38] Kamal M, Mohamed A, Fuller CD, et al.Outcomes of patients diagnosed with carcinoma metastatic to the neck from an unknown primary source and treated with intensity-modulated radiation therapy[J]. Cancer, 2018, 124(7):1415-1427. DOI: 10.1002/cncr.31235. [39] Lanzer M, Bachna-Rotter S, Graupp M, et al.Unknown primary of the head and neck: A long-term follow-up[J]. J Craniomaxillofac Surg, 2015, 43(4):574-579. DOI: 10.1016/j.jcms.2015.03.004. [40] Wallace A, Richards GM, Harari PM, et al.Head and neck squamous cell carcinoma from an unknown primary site[J]. Am J Otolaryngol, 2011, 32(4):286-290. DOI: 10.1016/j.amjoto.2010.05.004. [41] Cheraghlou S, Torabi SJ, Husain ZA, et al.HPV status in unknown primary head and neck cancer: prognosis and treatment outcomes[J]. Laryngoscope, 2019, 129(3):684-691. DOI: 10.1002/lary.27475. [42] Liu X, Li D, Li N, et al.Optimization of radiotherapy for neck carcinoma metastasis from unknown primary sites: a meta-analysis[J]. Oncotarget, 2016, 7(48):78736-78746. DOI: 10.18632/oncotarget.12852. [43] Straetmans J, Stuut M, Wagemakers S, et al.Tumor control of cervical lymph node metastases of unknown primary origin: the impact of the radiotherapy target volume[J]. Eur Arch Otorhinolaryngol, 2020, 277(6):1753-1761. DOI: 10.1007/s00405-020-05867-2. [44] Coskun HH, Ferlito A, Medina JE, et al.Retropharyngeal lymph node metastases in head and neck malignancies[J]. Head Neck, 2011, 33(10):1520-1529. DOI: 10.1002/hed.21526. [45] Du C, Ying H, Zhang Y, et al.Treatment for retropharyngeal metastatic undifferentiated squamous cell carcinoma from an unknown primary site: results of a prospective study with irradiation to nasopharyngeal mucosa plus bilateral neck[J]. Oncotarget, 2017, 8(26):42372-42381. DOI: 10.18632/oncotarget.16344. [46] 冯琨, 窦圣金, 朱国培, 等. 原发灶不明的颈部转移癌的放射治疗:选择性黏膜腔照射是否临床获益?[J]. 中国口腔颌面外科杂志, 2018, 16(03): 248-252. Feng K, Dou SJ, Zhu GP, et al.Radiotherapy for head and neck cancer of unknown primary sites: is there a clinical benefit to elective mucosal irradiation[J]. Chin J Oral Maxillofac Surg, 2018, 16(03): 248-252. [47] Chen AM, Meshman J, Hsu S, et al.Oropharynx-directed ipsilateral irradiation for p16-positive squamous cell carcinoma involving the cervical lymph nodes of unknown primary origin[J]. Head Neck, 2018, 40(2):227-232. DOI: 10.1002/hed.24906. [48] Sudoko CK, Polacco MA, Gosselin BJ, et al.Diagnostic value of lingual tonsillectomy in unknown primary head and neck carcinoma identification after a negative clinical workup and positron emission tomography-computed tomography[J]. Front Oncol, 2018, 8:118. DOI: 10.3389/fonc.2018.00118. [49] Hu KS, Mourad WF, Gamez ME, et al.Five-year outcomes of an oropharynx-directed treatment approach for unknown primary of the head and neck[J]. Oral Oncol, 2017, 70:14-22. DOI: 10.1016/j.oraloncology.2017.05.001. [50] Rödel RM, Matthias C, Blomeyer BD, et al.Impact of distant metastasis in patients with cervical lymph node metastases from cancer of an unknown primary site[J]. Ann Otol Rhinol Laryngol, 2009, 118(9):662-669. DOI: 10.1177/000348940911800911. [51] Cuaron J, Rao S, Wolden S, et al. Patterns of failure in patients with head and neck carcinoma of unknown primary treated with radiation therapy[J]. Head Neck, 2016, 38Suppl 1(Suppl 1):E426-431. DOI: 10.1002/hed.24013. [52] Maghami E, Ismaila N, Alvarez A, et al.Diagnosis and management of squamous cell carcinoma of unknown primary in the head and neck: ASCO guideline[J]. J Clin Oncol, 2020, 38(22):2570-2596. DOI: 10.1200/JCO.20.00275.
2022, Vol. 31 
